Silo Pharma implements 1-for-50 reverse stock split in preparation for Nasdaq uplisting

Silo Pharma, Inc.

Reverse split at ratio of 1-for-50 effective 4:01 p.m. ET on September 14, 2022.
Common stock will trade on OTC Markets under temporary symbol 'SILOD' until Nasdaq listing.
Post-split shares outstanding approximately 1,987,906; fractional shares rounded up.
Stockholders approved reverse split range at special meeting on March 11, 2022.
Company has filed Nasdaq listing application and believes it meets all requirements except minimum share price.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.